|
US5846534A
(en)
|
1988-02-12 |
1998-12-08 |
British Technology Group Limited |
Antibodies to the antigen campath-1
|
|
US6319494B1
(en)
|
1990-12-14 |
2001-11-20 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
|
US6867041B2
(en)
|
2000-02-24 |
2005-03-15 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
CA2406864A1
(en)
|
2000-02-24 |
2001-08-30 |
Life Technologies Corporation |
Simultaneous stimulation and concentration of cells
|
|
US6797514B2
(en)
|
2000-02-24 |
2004-09-28 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
MXPA05000511A
(es)
|
2001-07-12 |
2005-09-30 |
Jefferson Foote |
Anticuepros super humanizados.
|
|
EP3659435A1
(en)
*
|
2009-07-15 |
2020-06-03 |
Calimmune, Inc. |
Dual vector for inhibition of human immunodeficiency virus
|
|
WO2011146862A1
(en)
|
2010-05-21 |
2011-11-24 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing selective apoptosis
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
CN110200997A
(zh)
|
2011-03-23 |
2019-09-06 |
弗雷德哈钦森癌症研究中心 |
用于细胞免疫治疗的方法和组合物
|
|
CN103316356B
(zh)
|
2012-03-22 |
2016-08-17 |
北京三诺佳邑生物技术有限责任公司 |
一种重组慢病毒载体制剂
|
|
GB201206559D0
(en)
|
2012-04-13 |
2012-05-30 |
Ucl Business Plc |
Polypeptide
|
|
FR3010720B1
(fr)
|
2013-09-16 |
2017-08-11 |
Genethon |
Procede de production de virus enveloppes
|
|
FR3014901B1
(fr)
|
2013-12-17 |
2017-06-09 |
Genethon |
Procede de purification de virus ou vecteurs viraux enveloppes
|
|
JP2017505819A
(ja)
|
2014-02-04 |
2017-02-23 |
カイト ファーマ インコーポレイテッドＫｉｔｅ Ｐｈａｒｍａ， Ｉｎｃ |
Ｂ細胞悪性腫瘍及び他のがんの治療に有用な自己ｔ細胞を産生する方法、並びにその組成物
|
|
ES2869972T3
(es)
|
2015-01-26 |
2021-10-26 |
Cellectis |
Sistemas de receptores de antígenos quiméricos dirigidos por mAb para clasificar/agotar células inmunitarias genomanipuladas
|
|
EP3364969A4
(en)
*
|
2015-10-20 |
2019-07-10 |
Kite Pharma, Inc. |
METHOD FOR THE PRODUCTION OF T CELLS FOR T CELL THERAPY
|
|
IL261713B2
(en)
|
2016-03-19 |
2023-09-01 |
F1 Oncology Inc |
Methods and preparations for the transfer of lymphocytes and their regulated expansion
|
|
MY210545A
(en)
*
|
2016-04-01 |
2025-09-30 |
Kite Pharma Inc |
Chimeric receptors to flt3 and methods of use thereof
|
|
SG10202107808SA
(en)
|
2017-01-18 |
2021-08-30 |
F1 Oncology Inc |
Chimeric antigen receptors against axl or ror2 and methods of use thereof
|
|
WO2018136566A1
(en)
|
2017-01-18 |
2018-07-26 |
F1 Oncology, Inc. |
Methods of transducing and expanding immune cells and uses thereof
|
|
AU2018226884B2
(en)
|
2017-03-03 |
2024-11-07 |
Exuma Biotech, Corp. |
Methods and compositions for transducing and expanding lymphocytes and regulating the activity thereof
|